Cell Therapeutics and Hope Heart Institute entered into a 2 year research collaboration agreement to develop potential new cancer targets using HHI’s existing infrastructure and research in the field of vascular biology and tissue remodelling and CTI’s expertise in target identification, drug development and cancer research.